Limiting Offshore Coding Risks with the New Administration- CBS is here to help!

In an age where personal data security is more critical than ever, the handling of health information by healthcare providers and institutions faces unprecedented risks. Every time a person visits a doctor, clinic, or hospital, their private medical and demographic information is entered into electronic medical records (EMRs), creating a permanent and detailed history of their healthcare journey.

While the U.S. has implemented federal HIPAA regulations to protect this sensitive information, outsourcing the handling of these records to foreign countries could dangerously undermine patient privacy.

These risks become even more acute when we consider what might happen under the new U.S. Presidential Administration. On a wide variety of trade, data and intellectual property fronts, it is likely that there will be significant restrictions on the transfer of healthcare records out of the U.S. This looming issue makes the case for fully domestic Medical Coding and HIM even more pressing.

The Hidden Vulnerability in Electronic Medical Records

EMRs include a range of personal data beyond basic health details, such as social security numbers, home addresses, workplace information, prescription histories, and even family demographics like children’s schools. Sensitive mental and physical health information, including potentially stigmatizing diagnoses or explicit medical images, also lives within these records. Given the personal and sensitive nature of this data, any compromise could lead to severe consequences for individuals and their families, from identity theft to exposure of private health issues.

The Outsourcing Dilemma: Sacrificing Security for Savings

Over the past decade, healthcare providers increasingly turned to outsourcing companies based in countries like India, Pakistan, and the Philippines to manage HIM functions, primarily due to the cost savings of cheaper labor. Not only do these foreign resources often produce lower quality results than domestic coding firms, but these cost-saving measures introduce a substantial risk: these foreign workforces are not bound by HIPAA or U.S. privacy laws, leaving a critical gap in accountability and enforcement.

In the U.S., HIPAA regulations require strict controls to protect patient data, and the Department of Health and Human Services (HHS) Office for Civil Rights actively enforces these regulations. Violations can result in significant penalties for U.S.-based providers, coders, and contractors. Overseas entities, however, operate outside the reach of HIPAA and U.S. law. Even if a foreign outsourcing firm claims HIPAA compliance, there is no legal recourse if that compliance is not upheld. This reality leaves patients’ EMRs vulnerable to breaches and misuse without the protective recourse available within the U.S.

The Consequences of Data Exposure in Foreign Hands

Medical records have high black-market value, estimated at $100 to $1,000 per record. Cybersecurity experts warn that any patient information processed overseas faces an increased risk of being sold or leaked, with little accountability for the individuals or organizations that misuse it. If foreign workers mishandle or sell this information, U.S. patients have no legal remedy, and enforcement agencies like the HHS cannot prosecute foreign violations. The risk is magnified as foreign countries may lack the stringent data protection standards the U.S. maintains, making it easier for bad actors to access and exploit sensitive information.

Why U.S.-Based HIM Processing is Essential

The most effective solution to safeguarding patients’ privacy is to keep all HIM processing within the U.S. Here are key reasons why:

  1. Legal Protections and Accountability: Processing HIM within U.S. borders ensures that federal privacy laws like HIPAA apply. Domestic coders, record-keepers, and other HIM professionals are legally obligated to follow rigorous data protection standards. If a breach occurs, U.S. agencies can investigate, penalize, and ensure corrective action, holding violators accountable in a way that is impossible with foreign firms.
  2. Higher Standards and Compliance Assurance: U.S.-based HIM professionals are trained in HIPAA regulations, and their employers must pass routine audits and uphold security certifications. By contrast, foreign companies may not face the same rigorous standards, creating a lower threshold for compliance and increasing the risk of data compromise.
  3. National Security Concerns: The security of U.S. citizens’ personal and medical data is not merely a private concern but a matter of national security. With identity theft and fraud posing substantial risks to individuals and financial systems, any weakness in data security can ripple out into wider social and economic instability. U.S.-based processing helps mitigate these risks by keeping sensitive data within the country’s regulatory and legal reach.
  4. Probable Upcoming Legislation: We expect that their will be upcoming scrutiny of offshoring medical coding by the Trump administration, which could produce a seismic shift back towards fully domestic medical coding.
  5. Supporting Domestic Workforce and Privacy Protections: Moving HIM functions offshore not only endangers patient data but also erodes the U.S. job market for health information professionals. By keeping these jobs domestic, the U.S. strengthens its workforce in this critical sector, benefiting both privacy standards and the economy.

The Path Forward: Patient Privacy Before Cost Savings

While cost-saving incentives may drive healthcare institutions to consider outsourcing HIM functions, the potential consequences for patient privacy and security are simply too high. Patients trust that their healthcare providers will protect their most sensitive information. This trust can only be preserved by ensuring that data handling stays within the framework of U.S. laws, oversight, and accountability.

To truly protect patient privacy, healthcare institutions must prioritize domestic processing of HIM tasks. When patients can trust that their medical records remain protected by robust U.S. privacy laws, they can focus on their health with confidence and peace of mind.

To get ahead of any changes in government policies regarding the offshoring of HIM and medical coding, you may want to talk to the Team at Coding & Billing Solutions. Are superior results and 100% fully domestic approach are something your organization needs to consider.

 

Powered by Grey Matter Direct. Grey Matter Direct is a digital marketing agency in Mount Laurel, New Jersey, that specializes in website development, search engine optimization, email marketing, Google Ads and more.

Will You Be Joining Us At The HFMA 48th Anniversary Annual Institute?

Sheri Hovan and Mark Hovan from Coding & Billing Solutions will be at the New Jersey & Metro Philadelphia HFMA 48th Anniversary Annual Institute at the Atlantic City Hard Rock. Will you be there? If so, we would love to meet you.

The agenda looks to be timely and compelling. Here are some of this year’s topics:

  • Summary of the Federal Fiscal Year (FFY) 2025 Centers for Medicare & Medicaid Services’ (CMS) Final Rulings and Hot Reimbursement Topics
  • 2024 Legislative Update: Implications for Healthcare RCM Leaders
  • Declining Self-Pay Recovery Rates — Want to know why?
  • Strategies to unlocking potential and improving productivity
  • Medicare Enrollment Updates, Challenges, and Potential Penalties for Non Compliance
  • Understanding Observation Services in 2024
  • A Well-Oiled Machine: Departments Working Together for Better Reimbursement
  • Protecting Revenue with Automation Technology for Medicaid and Charity Care Enrollment
  • The New Data Privacy Laws, Update on Privacy Class Action Litigation, and Mitigating Privacy Risk Through Insurance
  • Navigating the Nexus: Understanding A.I. Opportunities and Cybersecurity Threats in Healthcare
  • Charting the Course: Building a Sustainable Health Care Workforce for the State of New Jersey
  • Never underestimate the power of a denial!
  • Coding Compliance and Risk Mitigation: Protecting Your Revenue
  • Managed Care Benchmarking in the Era of Price Transparency
  • Powering Value-Based Contract Success—Strategies to Empower Providers and Drive Operational Excellence
  • Fight Payer Denials with Final Rule CMS-4201-F
  • Is this the End of Agency Deference? The New Landscape of Administrative Law and the Impact on Healthcare Providers.
  • Lessons learned from a successful AI Implementation of Computer Assisted Coding
  • Monetizing Clean Energy Capital Improvements
  • Automating Data Governance to Support Effective Analytics
  • From Denial to Recovery: Upgrading Your Approach to DRG Downgrades
  • Navigating Compliance: Lessons from Recent Enforcement Activity
  • Utilizing Educational Relationships to Address Workforce Challenges

We look forward to seeing you there!

Sheri Hovan

President & CEO

Coding & Billing Solutions

Ovarian Cancer ICD 10 Codes – Coding & Billing Solutions

2024 ICD-10-CM Diagnosis Code C56

Malignant neoplasm of ovary

  • C56 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
  • The 2024 edition of ICD-10-CM C56 became effective on October 1, 2023.
  • This is the American ICD-10-CM version of C56 – other international versions of ICD-10 C56 may differ.

Use Additional code to identify any functional activity

The following code(s) above C56 contain annotation back-references

that may be applicable to C56:

  • C00-D49 – Neoplasms
  • C51-C58 – Malignant neoplasms of female genital organs


Clinical Information

  • A primary or metastatic malignant neoplasm involving the ovary. Most primary malignant ovarian neoplasms are either carcinomas (serous, mucinous, or endometrioid adenocarcinomas) or malignant germ cell tumors. Metastatic malignant neoplasms to the ovary include carcinomas, lymphomas, and melanomas.
  • A primary or metastatic malignant tumor involving the ovary. Most primary malignant ovarian neoplasms are either carcinomas (serous, mucinous, or endometrioid adenocarcinomas) or malignant germ cell tumors. Metastatic malignant neoplasms to the ovary include carcinomas, lymphomas, and melanomas.
  • Cancer that forms in tissues of the ovary (one of a pair of female reproductive glands in which the ova, or eggs, are formed). Most ovarian cancers are either ovarian epithelial carcinomas (cancer that begins in the cells on the surface of the ovary) or malignant germ cell tumors (cancer that begins in egg cells).
  • The ovaries are part of the female reproductive system. They produce a woman’s eggs and female hormones. Each ovary is about the size and shape of an almond.cancer of the ovary is not common, but it causes more deaths than other female reproductive cancers. The sooner ovarian cancer is found and treated, the better your chance for recovery. But ovarian cancer is hard to detect early. Women with ovarian cancer may have no symptoms or just mild symptoms until the disease is in an advanced stage. Then it is hard to treat. Symptoms may include
  • a heavy feeling in the pelvis
  • pain in the lower abdomen
  • bleeding from the vagina
  • weight gain or loss
  • abnormal periods
  • unexplained back pain that gets worse
  • gas, nausea, vomiting, or loss of appetite
  • to diagnose ovarian cancer, doctors do one or more tests. They include a physical exam, a pelvic exam, lab tests, ultrasound, or a biopsy. Treatment is usually surgery followed by chemotherapy. nih: national cancer institute

Code History

2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)

2017 (effective 10/1/2016): No change

2018 (effective 10/1/2017): No change

2019 (effective 10/1/2018): No change

2020 (effective 10/1/2019): No change

2021 (effective 10/1/2020): No change

2022 (effective 10/1/2021): No change

2023 (effective 10/1/2022): No change

2024 (effective 10/1/2023): No change

Code annotations containing back-references to C56:

Code First: R18.0

Type 1 Excludes: C75

Diagnosis Index entries containing back-references to C56:

  • Adenofibroma

endometrioid D27.9

malignant C56-

  • Brenner

tumor (benign) D27.9

malignant C56

  • Carcinoma (malignant) – see also Neoplasm, by site, malignant

granulosa cell C56-

  • Dermoid (cyst) – see also Neoplasm, benign, by site

with malignant transformation C56-

  • Teratoma (solid) – see also Neoplasm, uncertain behavior, by site

ovary

embryonal, immature or malignant C56-

  • Thecoma D27-

malignant C56-

  • Tumor – see also Neoplasm, unspecified behavior, by site

Brenner D27.9

malignant C56-

dermoid – see Neoplasm, benign, by site

with malignant transformation C56-

granulosa cell D39.1-

malignant C56-

granulosa cell-theca cell D39.1-

malignant C56-

papillary – see also Papilloma

mucinous of low malignant potential C56-

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Immune Thrombocytopenic Purpura ICD 10 Codes – Coding & Billing Solutions

The following is coding for Immune thrombocytopenic purpura ICD-10 Codes

2024 ICD-10-CM Diagnosis Code D69.3

  • D69.3 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • The 2024 edition of ICD-10-CM D69.3 became effective on October 1, 2023.
  • This is the American ICD-10-CM version of D69.3 – other international versions of ICD-10 D69.3 may differ.

Applicable To

  • Hemorrhagic (thrombocytopenic) purpura
  • Idiopathic thrombocytopenic purpura
  • Tidal platelet dysgenesis

The following code(s) above D69.3 contain annotation back-references

that may be applicable to D69.3:

  • D50-D89 – Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
  • D69 Purpura and other hemorrhagic conditions

Approximate Synonyms

  • Acute idiopathic thrombocytopenic purpura
  • Chronic idiopathic thrombocytopenic purpura
  • Idiopathic thrombocytopenia purpura (itp)
  • Idiopathic thrombocytopenic purpura
  • Idiopathic thrombocytopenic purpura, chronic
  • Purpura, idiopathic thrombocytopenia, acute

 

Clinical Information

  • A condition in which platelets (blood cells that cause blood clots to form) are destroyed by the immune system. The low platelet count causes easy bruising and bleeding, which may be seen as purple areas in the skin, mucous membranes, and outer linings of organs.
  • An autoimmune disorder in which the number of circulating platelets is reduced due to their antibody-mediated destruction. Itp is a diagnosis of exclusion and is heterogeneous in origin.
  • Bleeding or bruising tendency due to low platelet level
  • Thrombocytopenia occurring in the absence of toxic exposure or a disease associated with decreased platelets. It is mediated by immune mechanisms, in most cases immunoglobulin g autoantibodies which attach to platelets and subsequently undergo destruction by macrophages. The disease is seen in acute (affecting children) and chronic (adult) forms.

ICD-10-CM D69.3 is grouped within Diagnostic Related Group(s) (MS-DRG v41.0):

  • 813 Coagulation disorders

Convert D69.3 to ICD-9-CM

Code History

2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)

2017 (effective 10/1/2016): No change

2018 (effective 10/1/2017): No change

2019 (effective 10/1/2018): No change

2020 (effective 10/1/2019): No change

2021 (effective 10/1/2020): No change

2022 (effective 10/1/2021): No change

2023 (effective 10/1/2022): No change

2024 (effective 10/1/2023): No change

Code annotations containing back-references to D69.3:

  • Type 1 Excludes: D69.0

Diagnosis Index entries containing back-references to D69.3:

  • Dysgenesis

tidal platelet D69.3

  • Frank’s essential thrombocytopenia D69.3
  • Hemorrhage, hemorrhagic (concealed) R58

purpura D69.3 (primary)

  • Purpura D69.2

hemorrhagic, hemorrhagica D69.3

idiopathic (thrombocytopenic) D69.3

thrombocytopenic D69.49

hemorrhagic D69.3

idiopathic D69.3

immune D69.3

immune thrombocytopenic D69.3

  • Thrombocytopenia, thrombocytopenic D69.6

primary NEC D69.49

idiopathic D69.3

essential D69.3

idiopathic D69.3

  • Werlhof’s disease D69.3

ICD-10 Code For Atrial Fibrillation Overview

ICD-10 Code For Atrial Fibrillation Overview  ICD-10-CM Codes › I00-I99 › I30-I5A › I48- › 2023 ICD-10-CM Diagnosis Code I48.91

2023 ICD-10-CM Diagnosis Code I48.91

Unspecified atrial fibrillation

  • I48.91 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • The 2023 edition of ICD-10-CM I48.91 became effective on October 1, 2022.
  • This is the American ICD-10-CM version of I48.91 – other international versions of ICD-10 I48.91 may differ.

 

The following code(s) above I48.91 contain annotation back-references

that may be applicable to I48.91:

  • I00-I99 -Diseases of the circulatory system

Approximate Synonyms

  • Atrial fibrillation
  • Atrial fibrillation with rapid ventricular response

 

ICD-10-CM I48.91 is grouped within Diagnostic Related Group(s) (MS-DRG v40.0):

  • 308 Cardiac arrhythmia and conduction disorders with mcc
  • 309 Cardiac arrhythmia and conduction disorders with cc
  • 310 Cardiac arrhythmia and conduction disorders without cc/mcc
  • 791 Prematurity with major problems
  • 793 Full term neonate with major problems

Convert I48.91 to ICD-9-CM

Code History

2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)

2017 (effective 10/1/2016): No change

2018 (effective 10/1/2017): No change

2019 (effective 10/1/2018): No change

2020 (effective 10/1/2019): No change

2021 (effective 10/1/2020): No change

2022 (effective 10/1/2021): No change

2023 (effective 10/1/2022): No change

Diagnosis Index entries containing back-references to I48.91:

  • Fibrillation

atrial or auricular (established) I48.91

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Is Someone You Know Struggling With Substance Abuse? Here Are Some Tips On How To Help

With the occasion of International Overdose Awareness Day, people close to us with substance abuse issues are in our thoughts. America’s ongoing addiction crisis is a problem that is close to the hearts of the Team at Coding & Billing Solutions. In fact, our annual Golf Classic is dedicated to helping children who have been impacted by addiction.

Do you have an adult family member or friend struggling with drug or alcohol abuse? You’re likely wondering how to help. The following are some questions to ask and some tips on how to help.

Am I Overreacting to a Substance Use Problem?

If you’re noticing issues in your loved one’s work, health, relationships, finances, or social life, you’re not overreacting. Continuing to use substances despite these problems is a clear sign that substance use has become a significant issue. When someone is unwilling to discuss their behavior or consider that there might be a problem, it’s a strong indicator that a problem exists.

What You Can Do:

  1. Educate Yourself: Learn about the signs and symptoms of substance use.
  2. Observe Behavior: Monitor the person’s actions over days or weeks to gather information. This can be helpful if you decide to talk to other family members, seek professional advice, or address the person directly.
  3. Share Concerns: Discuss your observations with other family members and friends to gauge their perspective. If they agree, decide who will talk to the person about seeking help.
  4. Seek Professional Advice: Contact a substance use professional, mental health professional, or other trusted experts to describe the situation and get their assessment.
  5. Ensure Safety: If there’s any risk of physical or emotional harm, develop a safety plan.

The Benefits of Taking Action Early

The idea that someone must “hit bottom” before they can be helped is a myth. Research shows that early identification of substance use problems is far more effective. Catching the issue early—before significant damage occurs—leads to better outcomes. Early intervention might involve a health screening or a conversation with a professional. Treatment is often less intense and disruptive when the problem is addressed early.

Don’t wait for a crisis to take action. Without intervention, you may face severe consequences like arrests, medical emergencies, job loss, and even death. Moreover, untreated substance use can lead to additional problems for family members, such as health issues, depression, anxiety, and even substance use problems in children.

How to Raise the Subject

You might worry that bringing up the issue will lead to drastic reactions. However, the conversation could be productive. The person might not realize the extent of their problem or its impact on others. Without change, the situation could worsen, leading to the very outcomes you fear.

Tips for a Successful Conversation:

  1. Choose the Right Time: Don’t bring up the subject when either of you is under the influence of substances.
  2. Plan Ahead: Find a time when you can talk privately and without interruptions. Aim for a dialogue where both of you can express your thoughts.
  3. Express Concern: Start by showing that you care for the person and are concerned for their well-being.
  4. Be Specific: List the behaviors that worry you and explain how they’ve impacted you and others.
  5. Encourage Dialogue: Ask open-ended questions and listen to their perspective without judgment.
  6. Follow Up: If the person denies there’s a problem, suggest revisiting the conversation later. Your goal is to express your concerns, not to force an immediate change.

What If They Can’t Cut Back?

If the person has only recently developed a problem, they might be able to cut back on their own. However, many people who try to reduce their use find that they can’t sustain it for long. This realization may help them understand that the problem is more serious than they thought. If the person is willing to consider that there’s a problem, suggest getting an evaluation from a professional.

How to Help a Friend Understand They Need Help

If you’ve tried expressing your concerns repeatedly without seeing any change, focus on delivering a consistent, positive message: “We care about you and want you to get help.” Avoid blaming or arguing, as these can lead to denial and defensiveness.

Consider involving other trusted individuals—such as a friend, doctor, or clergy member—who might be able to reach the person in ways you haven’t been able to.

DOs and DON’Ts

  • Don’t try to talk when either of you is under the influence.
  • Do protect yourself and others from physical harm.
  • Do call the police if there is violence.
  • Do set and stick to limits that protect your home, finances, and relationships.

If you’re at your wits’ end, a formal intervention might be necessary.

How to Help a Loved One Get the Care They Need

When people think of treatment for substance use, they often imagine long-term residential facilities or detox. However, treatment options vary widely and are tailored to the individual’s needs. Treatment addresses physical, psychological, emotional, and social aspects of the person’s life.

Treatment Steps:

  1. Screening: This involves questions about substance use and its impact. It can be done by various professionals, including doctors and counselors.
  2. Brief Intervention: If a problem is identified, the person may receive feedback and be asked to cut back or stop their use. If they’re willing to make changes, a health professional can help set goals and offer support.
  3. Ongoing Support: If necessary, the person may be referred for more intensive treatment. Any number of programs can be effective if the person is willing to engage.

To find a treatment program, visit SAMHSA’s Behavioral Health Treatment Services Locator.

What to Do in an Emergency

If your loved one shows any of the following symptoms, call 911 or emergency services immediately:

  • Loss of consciousness after taking drugs or alcohol.
  • Seizures.
  • Suicidal thoughts after drinking or drug use.
  • Severe withdrawal symptoms, such as confusion or tremors.

Getting help for someone struggling with substance use is never easy, but taking action is crucial for their well-being and the well-being of those around them.

 

Powered by Grey Matter Direct. Grey Matter Direct is a digital marketing agency in Mount Laurel, New Jersey, that specializes in website development, search engine optimization, email marketing, Google Ads and more.

CPT Codes For Addiction Treatment

Due to the ongoing addiction crisis in the United States, the need for treatment has grown significantly. For those clinics and treatment centers that are at the forefront of this medical emergency, proper implementation of CPT codes for addiction treatment is essential.

Coding & Billing Solutions has deep expertise in addiction treatment coding and compliance and has clients like New Life Medical Addiction Services, which has turned over all of its medical coding and billing to the CBS Team. “Sheri and her coding team have become an indispensable part of the extended New Life Team. Not only have they streamlined our medical coding, they have provided us with valuable insights and coding tips that have allowed us to claim more revenue from the services we provide while also facilitating a better patient experience and outcome” said Dr. Joseph Savon, Chief Medical Officer and Co-Founder of New Life.

The CBS Team is constantly reviewing the latest standards for medical coding for substance abuse treatment. In this post we will review 3 of the most used CPT codes for addiction treatment and how they should be implemented in your treatment center’s coding and billing operation.

Modifiers for Addiction Treatment Billing CPT Codes

In CPT codes for addiction treatment, most of the base code is the same, but it is the alpha modifiers that facilitate proper detailed coding.

The following are some of the most common CPT code modifiers for addiction treatment billing:

HA: For programs dealing with children under 18

HB: For programs dealing with adults younger than geriatric age.

HD: Used for programs designed for pregnant and parenting women.

HF: Substance use programs

HV: Used for addiction services that are funded by the state.

TG: Designates programs that deliver a complex and/or high level of care.

The Following Is An Overview Of The CPT Codes For Addiction Treatment

Addiction Treatment Billing CPT Code – H0001HF

H0001HF is a CPT code that refers to drug and alcohol assessments for SUD (Substance Use Disorder) treatment.

The CPT code for this is “H0001” and the modifier for this is “HF.” H0001 refers to time that counselors, doctors, and other clinicians spend performing alcohol and drug assessments with clients in the course of treatment for SUDs. The HF modifier is the indication that the billable hours are taking place in the context of a substance use program.

This code is used when conducting assessments with clients to determine the presence and severity of SUD in the course of creating and updating their treatment plans at an addiction treatment facility.

Addiction Treatment Billing CPT Code – H0004HF

H0004HF is a CPT code that refers to individual therapy/one-on-one counseling in an addiction treatment environment.

The CPT code for this is “H0004” and the modifier for this is “HF.” H0004 describes time spent doing individual counseling with a client and the inclusion of the modifier, HF, indicates that these billable hours have occurrent within the context of a substance use program. Please note that this code can only be used for sessions with an individual patient and not for sessions involving the patient’s friends or family,

Each instance of this code corresponds to 15 minutes of service. Accordingly, if sessions are one hour long, this code needs to be submitted four times to account for the four 15-minute blocks of individual therapy that occurred on that day.

Addiction Treatment Billing CPT Code – 96164HF

96164HF is a CPT code for group counseling done in a face-to-face setting in an addiction treatment program.

The CPT code is “96164” and the modifier is “HF.” The CPT code, 96164, represents face-to-face (in-person) group counseling and the HF modifier is used to communicate that the service took place in a substance use program. This code is used to describe the first 30 minutes of any behavioral health group session.

When billing for any of these CPT codes, it’s often recommended to provide a taxonomy code that describes the facility by provider type and/or specialization. The taxonomy code that is most often used for this is 261QR0405X which describes a provider that specializes in addressing substance use disorders.

CBS Has Addiction Treatment Expertise

Are you a substance abuse or addiction treatment facility and you would like to discuss how Coding & Billing Solutions can help you with medical coding and compliance, contact us today!

Epic Systems is Integrating AI Features Into Its Systems. Here’s What You Need To Know

In its recent UGM (User Group Meeting) at its Verona, Wisconsin, Epic Systems announced a series of announcements involving its expanded use of artificial intelligence in its systems. The following are some of the highlights:

  1. Many of Epic’s announcements were focused on how the software company is integrating artificial intelligence into its products. Epic Systems CEO Judy Faulkner said that Epic has more than 100 AI features in the works, though many of the tools are still in the early stages of development.
  2. Faulkner said that by the end of 2025 its generative AI will help doctors convert message responses, letters and instructions into plain language that patients can easily understand.
  3. Doctors will be able to use AI to automatically queue up orders for prescriptions and labs, the company said.
  4. In order to help physicians streamline time-consuming tasks such as reviewing prior authorization requirements and drafting insurance denial appeal letters, Epic said it is working to introduce AI tools that can streamline those processes this year.
  5. Epic announced that by the end of 2025, its generative AI will be able to pull in the results, medications and other details that a doctor might need when responding to a patient’s message through MyChart. Other specific functions, like using artificial intelligence to calculate wound measurements from images, will also be arriving by 2025.
  6. Epic announced plans for a new staff scheduling application for physicians and nurses called “Teamwork” that’s coming soon.
  7. Judy Faulkner also explained that Epic is “investigating” how it could facilitate claims submissions directly through its software, without the need for a middleman like a clearinghouse. If Epic is successful, it could mark a major change in the way that insurance claims are processed throughout the health-care industry.

These announced changes are very significant, and it is yet to be seen as to whether they will operate as promised and the extent to which the industry will adopt these changes.

Whether these features will all come to fruition — and whether health systems will actually use them — isn’t yet known. Even so, Epic ended its presentation Tuesday by showcasing a demo about where the company believes its technology can go.

The Future of Epic Systems

In a demo about the future of its systems, Seth Hain, senior vice president of research and development at Epic, was the facilitator. Seth spoke to an artificial intelligence agent through the MyChart app about his recovery after a hypothetical wrist surgery and answered questions about his pain. The AI agent instructed Hain to open his camera and bend his wrist back so it could evaluate the progress of his healing. The agent said Hain’s wrist extension was about 60 to 75 degrees, which meant his recovery was ahead of schedule, compared to data from similar patients in Epic’s Cosmos database.

Hain then asked the agent if he could start playing pickleball again, and it told him that he “should still wait a little longer” before doing so.

In a meeting with reporters after the presentation, Hain said the demo was happening in real-time without human intervention. However, that capability is so new that Epic doesn’t even have a name for it yet, and Hain said it will likely be a few years before it’s more widely available.

″It is very, very, very early in regards to how and where the community, the broader medical community, will adopt that type of thing, but it’s viable,” he said.

At CBS, we will be monitoring Epic’s developments in AI very carefully and advising our clients on how to best manage these changes.

Psoriasis ICD 10 Code Overview

2024 ICD-10-CM Diagnosis Code L40.9

Psoriasis, unspecified

L40.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.

The 2023 edition of ICD-10-CM L40.9 became effective on October 1, 2022.

This is the American ICD-10-CM version of L40.9 – other international versions of ICD-10 L40.9 may differ.

The following code(s) above L40.9 contain annotation back-references

that may be applicable to L40.9:

L00-L99 – Diseases of the skin and subcutaneous tissue

Approximate Synonyms

Psoriasis

Clinical Information

  • A chronic disease of the skin marked by red patches covered with white scales.
  • A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. Psoriatic lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region; the pathology involves an accelerated epidermopoiesis. Psoriasis is associated with increased risk for melanoma, squamous cell carcinoma, and basal cell carcinoma.
  • A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.
  • Common polygenetically determined, chronic, squamous dermatosis characterized by rounded erythematous, dry, scaling patches.
  • Psoriasis is a skin disease that causes itchy or sore patches of thick, red skin with silvery scales. You usually get them on your elbows, knees, scalp, back, face, palms and feet, but they can show up on other parts of your body. A problem with your immune system causes psoriasis. In a process called cell turnover, skin cells that grow deep in your skin rise to the surface. Normally, this takes a month. In psoriasis, it happens in just days because your cells rise too fast. Psoriasis can last a long time, even a lifetime. Symptoms come and go. Things that make them worse include
    • infections
    • stress
    • dry skin
    • certain medicines
  • psoriasis usually occurs in adults. It sometimes runs in families. Treatments include creams, medications and light therapy. nih: national institute of arthritis and musculoskeletal and skin diseases

ICD-10-CM L40.9 is grouped within Diagnostic Related Group(s) (MS-DRG v40.0):

  • 595 Major skin disorders with mcc
  • 596 Major skin disorders without mcc

Convert L40.9 to ICD-9-CM

Code History

  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
  • 2022 (effective 10/1/2021): No change
  • 2023 (effective 10/1/2022): No change

Diagnosis Index entries containing back-references to L40.9:

Psoriasis L40.9

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Healthcare Systems are Facing Unprecedented Economic Challenges. CBS Can Turn These into Opportunities

A recent study by The American Hospital Association showed that America’s hospitals and health systems are experiencing unique and transformational challenges. They simultaneously face increased demand for acute care services while enduring significant operational and reimbursement challenges.

Critical staffing shortages, supply chain disruptions for drugs and medical supplies, and high inflation rates have driven up hospital costs as they provide around-the-clock patient care. At the same time, hospitals are dealing with insufficient reimbursement increases from government payers and rising administrative burdens due to problematic practices by commercial health insurers.

These combined challenges have created financial uncertainty, leaving many hospitals and health systems operating with greatly reduced profit margins or no profits at all. Although recent data cited in the AHA report indicates a slight stabilization in finances from the historic lows of 2022, the sector is still far from meeting the necessary levels to address care demand, invest in new technologies and interventions, and prepare for future health care crises.

In 2022, the latest year with available data, hospitals admitted nearly 137 million patients to emergency departments and delivered over 3.5 million babies. Many of these critical services are highly resource-intensive and expensive to provide. The situation is further complicated by demographic trends like an aging population and clinical factors such as increased patient acuity. This has led to a steady rise in the proportion of inpatient utilization among more clinically complex patients covered by Medicare and Medicaid. Inpatient services are not only costlier to provide, but public payer payments for these services are significantly below the actual costs.

Some of the alarming developments that the AHA study found include:

  • Underpayments from Medicare and Medicaid totaled nearly $130 billion in 2022, and Medicare paid just 82 cents for every dollar hospitals spent caring for patients, which resulted in a shortfall of almost $100 billion.
  • Reimbursements for inpatient behavioral health services were 34.3% below costs across all payers on average in 2023, according to data from Strata Decision Technology
  • Commercial health insurers have burdened hospitals with time-consuming and labor-intensive practices like automatic claims denials and onerous prior authorization requirements
  • A 2021 study by McKinsey estimated that hospitals spent $10 billion annually on dealing with insurer prior authorizations. Furthermore, a 2023 study by Premier found that hospitals are spending just under $20 billion annually appealing denials — more than half which was spent on claims that should have been paid out at the time of submission.
  • Costly burn and wound services were 42.9% below costs across all payers.
  • Denials issued by commercial MA plans rose sharply by 55.7% in 2023.14 Notably, many of these denials were ultimately overturned.

If your private practice, hospital or healthcare system is being hurt by these developments, then you should consider talking to Coding & Billing Solutions. Our experienced management team and fully domestic coding staff have been helping our clients navigate these difficult challenges through reduced denials and improved coding outcomes.

Contact us today to talk about how CBS can help.

 

Powered by Grey Matter Direct. Grey Matter Direct is a digital marketing agency in Mount Laurel, New Jersey, that specializes in website development, search engine optimization, email marketing, Google Ads and more.